Live Quote · NASDAQGLUEHealthcare· Biotechnology

Monte Rosa Therapeutics, Inc.

$8.64▼ 3.03%($-0.27)
MKT CAP $738.29MNEXT EARNINGS Mar 16, 2027
50%
Bullish
TickerSpark Score
66/100
▌ Solid
80
Valuation
40
Profitability
100
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GLUE research report →

Analyst Price Target
$24.83+187.4% vs. today

Range $19 – $28

Analyst RatingBuy
8 Buy2 Hold0 Sell

Price Chart

-36.99% · this period
$25.31$17.11$8.91Nov 19May 22Nov 19
52-Week Range1% of range
Low
$8.48
Current
$8.64
High
$25.77